㈱TL Genomics
1 known investors
Develops a PCR-based chromosome testing technology called SinChro™ that measures cellular aging to assess natural fertility potential. Offers a fertility testing service and is developing in-vitro diagnostics to detect chromosomal abnormalities in myelodysplastic syndrome.
Investors · 1
Frequently asked questions
- What does ㈱TL Genomics do?
- Develops a PCR-based chromosome testing technology called SinChro™ that measures cellular aging to assess natural fertility potential. Offers a fertility testing service and is developing in-vitro diagnostics to detect chromosomal abnormalities in myelodysplastic syndrome.
- Who are ㈱TL Genomics's investors?
- ㈱TL Genomics's investors include DBJ Capital.